Yubo International Biotech (YBGJ) Financial Statements
Yubo International Biotech Financial Overview
Yubo International Biotech's market cap is currently $920.27K. The company's EPS TTM is $-0.00; its P/E ratio is -0.83; Yubo International Biotech has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 134.39K | $ 3.47K | $ 104.28K | $ 1.24M | $ 1.35M |
| Gross Profit | $ 8.16K | $ -209.28K | $ 52.65K | $ 820.65K | $ 1.24M |
| Operating Income | $ -1.19M | $ -1.77M | $ -1.21M | $ -1.54M | $ -711.80K |
| EBITDA | $ -1.01M | $ -1.80M | $ -1.18M | $ -1.52M | $ -698.74K |
| Net Income | $ -1.08M | $ -1.78M | $ -1.20M | $ -1.54M | $ -711.80K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.06K | $ 7.01K | $ 18.22K | $ 27.52K | $ 1.38M |
| Total Assets | $ 847.09K | $ 1.53M | $ 2.35M | $ 4.59M | $ 2.44M |
| Total Debt | $ 78.78K | $ 478.76K | $ 790.50K | $ 2.69M | $ 315.21K |
| Net Debt | $ 70.72K | $ 471.75K | $ 772.28K | $ 2.67M | $ -1.07M |
| Total Liabilities | $ 2.79M | $ 4.83M | $ 2.91M | $ 4.72M | $ 1.28M |
| Stockholders' Equity | $ -1.95M | $ -3.42M | $ -565.37K | $ -131.20K | $ 1.17M |
| Cash Flow | |||||
| Free Cash Flow | $ -842.80K | $ -1.34M | $ 28.46K | $ -1.59M | $ 3.64K |
| Operating Cash Flow | $ -842.80K | $ -1.34M | $ 68.23K | $ -1.02M | $ 101.11K |
| Investing Cash Flow | $ 0.00 | $ 118.43K | $ -39.77K | $ -564.72K | $ -97.47K |
| Financing Cash Flow | $ 849.54K | $ 1.41M | $ 0.00 | $ 127.16K | $ 1.38M |
Currency in USD
